Concepedia

Pamela B. Allen

PB

22

Publications

618

Citations

15

H-Index

2014

Active since

Affiliations

Emory University(Current)

Northwestern University

Winship Cancer Institute

Dana-Farber Cancer Institute

Rutgers Cancer Institute

Pamela B. Allen is an author at Emory University specializing in immunology, medicine, and pathology.

ORCID

Top concepts

Publications per year

2014–2024

22

Publications

22

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma

Pamela B. Allen, Hatice Savas, Andrew M. Evens et al. · Blood · 2020 · 135 citations · Full text

Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma

Locke J. Bryan, Carla Casulo, Pamela B. Allen et al. · JAMA Oncology · 2023 · 55 citations · Full text

Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study

Yuqin Song, Luis Malpica, Qingqing Cai et al. · The Lancet Oncology · 2023 · 43 citations

, , +8

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas et al. · The Lancet Diabetes & Endocrinology · 2023 · 34 citations · Full text

Tracheomegaly in Infants with Severe Congenital Diaphragmatic Hernia Treated with Fetal Endoluminal Tracheal Occlusion

Augusto Zani, Maria E. Sellars, Pamela B. Allen et al. · The Journal of Pediatrics · 2014 · 31 citations

, , +2

Rows per page

1–5 of 22